Search
for

    Sort by

    Research 331–360 of 499

    1. Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice 2023
    2. Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice 2023
    3. “Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors Journal of the American Academy of Dermatology · 2013 · 3 citations
    4. Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review Clinical Cosmetic and Investigational Dermatology · 2025 · 1 citations
    5. 1030 EGFR protects the upper hair follicle from staphylococcus driven folliculitis Journal of Investigative Dermatology · 2023
    6. Dermatologic adverse events associated with afatinib: an oral ErbB family blocker Expert Review of Anticancer Therapy · 2013 · 87 citations
    7. Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib Journal of the American Academy of Dermatology · 2006 · 57 citations
    8. Persistent hair growth during treatment with the EGFR inhibitor erlotinib Dermatology Online Journal · 2009 · 39 citations
    9. Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib Journal of the American Academy of Dermatology · 2011 · 32 citations
    10. Chloracne: histopathologic findings in one case Journal of cutaneous pathology · 2002 · 18 citations
    11. A comedonal variant of chronic cutaneous lupus erythematosus: Case report and literature review JAAD case reports · 2019 · 8 citations
    12. Folliculitis decalvans managed with adalimumab: A case report Clinical Case Reports · 2023 · 5 citations
    13. “PRIDE” Complex Indian Journal of Drugs in Dermatology · 2019 · 3 citations
    14. Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab) Journal of Clinical Oncology · 2008 · 3 citations
    15. Dermatoloji Polikliniğine Başvuran Hastaların Geleneksel ve Tamamlayıcı Tıp Uygulamaları Konuralp Tip Dergisi · 2020 · 2 citations
    16. Spotlight commentary: Navigating the cutaneous side effects of chemotherapy British Journal of Clinical Pharmacology · 2025
    17. Risk factors and comorbidities associated with central centrifugal cicatricial alopecia International journal of women’s dermatology · 2023
    18. Malassezia Folliculitis 2013
    19. Rapidly progressing mycosis fungoides presenting as follicular mucinosis Journal of the American Academy of Dermatology · 2000 · 76 citations
    20. The clinical features and histopathologic patterns of folliculotropic mycosis fungoides in a series of 38 cases Journal of Cutaneous Pathology · 2014 · 46 citations
    21. Ingestion of a dietary supplement resulting in selenium toxicity Journal of the American Academy of Dermatology · 2010 · 27 citations
    22. Cosmetics for the elderly Clinics in dermatology · 2001 · 21 citations
    23. Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin Expert Review of Dermatology · 2008 · 19 citations
    24. The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus Supportive Care in Cancer · 2023 · 15 citations
    25. Follicular contact dermatitis revisited: A review emphasizing neomycin-associated follicular contact dermatitis World journal of clinical cases · 2014 · 9 citations
    26. EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines Anti-Cancer Drugs · 2023 · 7 citations
    27. Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment Annals of palliative medicine · 2019 · 7 citations
    28. Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution Cancers · 2024 · 3 citations
    29. Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment Journal of Cancer Research and Therapeutics · 2019 · 3 citations
    30. Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases Current Allergy and Asthma Reports · 2022 · 2 citations